0001213900-22-063945.txt : 20221013
0001213900-22-063945.hdr.sgml : 20221013
20221013200532
ACCESSION NUMBER: 0001213900-22-063945
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221012
FILED AS OF DATE: 20221013
DATE AS OF CHANGE: 20221013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EMSTER KURT VON
CENTRAL INDEX KEY: 0001252524
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 221310037
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD
STREET 2: SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2022-10-12
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001252524
EMSTER KURT VON
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE #102
REDWOOD CITY
CA
94065
1
0
0
0
Voting Common Stock
2022-10-12
4
A
0
30250
0.00
A
30250
D
The reported securities are represented by restricted stock units (the "RSU Award"), 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
The Reporting Person is no longer deemed to share an indirect pecuniary interest in the securities held by Abingworth Bioventures VII, LP, and therefore no longer reports those securities on his Section 16 reports.
By: /s/ Jeet Mahal, as Attorney-in-Fact
2022-10-13